Literature DB >> 8678937

Treatment of benign prostatic hyperplasia.

P C Walsh.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8678937     DOI: 10.1056/NEJM199608223350809

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  13 in total

Review 1.  Botulinum A toxin for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms.

Authors:  Catherine A Thomas; Yao-Chi Chuang; Antonella Giannantoni; Michael B Chancellor
Journal:  Curr Urol Rep       Date:  2006-07       Impact factor: 3.092

2.  What is the best medical treatment for benign prostate hyperplasia?

Authors:  M F Evans; J Frank
Journal:  Can Fam Physician       Date:  1997-06       Impact factor: 3.275

Review 3.  Urinary incontinence in the elderly. Causes and treatment options.

Authors:  S Z Nasr; J G Ouslander
Journal:  Drugs Aging       Date:  1998-05       Impact factor: 3.923

Review 4.  Serenoa repens (Permixon). A review of its pharmacology and therapeutic efficacy in benign prostatic hyperplasia.

Authors:  G L Plosker; R N Brogden
Journal:  Drugs Aging       Date:  1996-11       Impact factor: 3.923

Review 5.  Benign prostatic hyperplasia. Practical treatment guidelines.

Authors:  T Tammela
Journal:  Drugs Aging       Date:  1997-05       Impact factor: 3.923

Review 6.  Management of bladder, prostatic and pelvic floor disorders.

Authors:  G Brisinda; G Maria; A R Bentivoglio; F Cadeddu; G Marniga; F Brandara; A Albanese
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

Review 7.  Treatment of benign prostatic hyperplasia. A pharmacoeconomic perspective.

Authors:  L M Eri; K J Tveter
Journal:  Drugs Aging       Date:  1997-02       Impact factor: 3.923

Review 8.  New intraprostatic injectables and prostatic urethral lift for male LUTS.

Authors:  Giuseppe Magistro; Christian G Stief; Christian Gratzke
Journal:  Nat Rev Urol       Date:  2015-07-21       Impact factor: 14.432

Review 9.  Urinary incontinence in the elderly. Drug treatment options.

Authors:  D S Chutka; P Y Takahashi
Journal:  Drugs       Date:  1998-10       Impact factor: 9.546

Review 10.  [Botulinum toxin in the treatment of benign prostatic hyperplasia : an overview].

Authors:  S Boy; C Seif; P M Braun; K-P Jünemann
Journal:  Urologe A       Date:  2008-11       Impact factor: 0.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.